Philippe AubySummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trialTram K Tran-Johnson
California Neuropsychopharmacology Clinical Research Institute, San Diego, Calif 92126, USA
J Clin Psychiatry 68:111-9. 2007....
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazoleDan L Zimbroff
Pacific Clinical Research Medical Group, Upland, CA 91786, USA
J Clin Psychopharmacol 27:171-6. 2007..3%) and IM lorazepam (19.1%). IM aripiprazole 9.75 and 15 mg are effective and well tolerated for acute agitation in bipolar disorder, although the low incidence of oversedation suggests a risk-benefit profile for IM aripiprazole 9.75 mg...
Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription databaseJohannes Hamann
Center for Disease Management, Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany
Int Clin Psychopharmacol 18:237-42. 2003..It is important to raise awareness among non-specialists about the indications, efficacy and side-effects of the antipsychotics because these physicians account for the majority of antipsychotic prescriptions...
